Skip to main content

Para mag-trade sa US, pumunta sa polymarket.us

icon for Mga kaso ng tigdas sa US sa 2026?
Klima At Agham·Pandemya

Mga kaso ng tigdas sa US sa 2026?

icon for Mga kaso ng tigdas sa US sa 2026?
Klima At Agham·Pandemya

Mga kaso ng tigdas sa US sa 2026?

Oct 1

Jan 1, 2027

Oct 1

Jan 1, 2027

Polymarket

$7,894,722 Vol.

Polymarket

$7,894,722 Vol.

↑3.5k

$15,502 Vol.

100%

↑4k

$240,759 Vol.

96%

↑4.5k

$2,485 Vol.

87%

↑4.75k

$568 Vol.

82%

↑5k

$241,133 Vol.

64%

↑7.5k

$193,280 Vol.

15%

↑10k

$6,524,515 Vol.

7%

↑12.5k

$356,524 Vol.

2%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, CDC data show 3,134 confirmed U.S. measles cases year-to-date—the highest annual total since 1991—driven by persistent outbreaks in Pennsylvania (over 550 cases), South Carolina, Utah, and several other states, with 95% outbreak-associated and 94% of patients unvaccinated or with unknown status. This surge exceeds 2025’s full-year count of 2,289 and stems from declining MMR coverage in under-vaccinated communities, enabling sustained local transmission of the highly contagious airborne virus. Trader sentiment for 2026 totals centers on weekly CDC surveillance updates and state reporting, which track case thresholds, hospitalization rates around 8%, and any shift toward endemic status, amid model projections of further spread before year-end.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,894,722
Petsa ng Pagtatapos
Jan 1, 2027
Binuksan ang Market
Jun 30, 2026, 2:17 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, CDC data show 3,134 confirmed U.S. measles cases year-to-date—the highest annual total since 1991—driven by persistent outbreaks in Pennsylvania (over 550 cases), South Carolina, Utah, and several other states, with 95% outbreak-associated and 94% of patients unvaccinated or with unknown status. This surge exceeds 2025’s full-year count of 2,289 and stems from declining MMR coverage in under-vaccinated communities, enabling sustained local transmission of the highly contagious airborne virus. Trader sentiment for 2026 totals centers on weekly CDC surveillance updates and state reporting, which track case thresholds, hospitalization rates around 8%, and any shift toward endemic status, amid model projections of further spread before year-end.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,894,722
Petsa ng Pagtatapos
Jan 1, 2027
Binuksan ang Market
Jun 30, 2026, 2:17 PM ET

Resolver

0x65070BE91...

Kaugnay

icon for Will there be at least 3200+ measles cases in the U.S. by September 30, 2026?

Will there be at least 3200+ measles cases in the U.S. by September 30, 2026?

99%
icon for Will South Sudan have an Ebola case in 2026?

Will South Sudan have an Ebola case in 2026?

65%
icon for New pandemic in 2026?

New pandemic in 2026?

6%

Mag-ingat sa mga external link.

Mga Madalas na Tanong

Ang "Mga kaso ng tigdas sa US sa 2026?" ay isang prediction market sa Polymarket na may 12 posibleng outcomes kung saan bumibili at nagbebenta ang mga trader ng shares batay sa kanilang pinaniniwalaan na mangyayari. Ang kasalukuyang nangunguna ay "↑3.5k" sa 100%, sinusundan ng "↑500" sa 100%. Ang mga presyo ay sumasalamin sa real-time crowd-sourced probabilities. Halimbawa, ang isang share na naka-presyo sa 100¢ ay nagpapahiwatig na kolektibong itinatakda ng market ang 100% na tsansa sa outcome na iyon. Patuloy na nagbabago ang mga odds na ito habang tumutugon ang mga trader sa mga bagong development at impormasyon. Ang mga shares sa tamang outcome ay mare-redeem sa $1 bawat isa sa market resolution.

Sa ngayon, ang "Mga kaso ng tigdas sa US sa 2026?" ay naka-generate ng $7.9 million sa kabuuang trading volume mula nang ilunsad ang market noong Dec 1, 2025. Ang antas na ito ng trading activity ay sumasalamin sa malakas na engagement mula sa Polymarket community at tumutulong na matiyak na ang kasalukuyang odds ay sinusuportahan ng malawak na pool ng mga market participant. Maaari mong subaybayan ang live price movements at mag-trade sa anumang outcome nang direkta sa pahinang ito.

Para mag-trade sa "Mga kaso ng tigdas sa US sa 2026?," i-browse ang 12 available na outcomes na nakalista sa pahinang ito. Ang bawat outcome ay may kasalukuyang presyo na kumakatawan sa implied probability ng market. Para kumuha ng posisyon, piliin ang outcome na pinaniniwalaan mong pinaka-malamang, piliin ang "Yes" para mag-trade pabor dito o "No" para mag-trade laban dito, ilagay ang iyong halaga, at i-click ang "Trade." Kung tama ang iyong napiling outcome kapag na-resolve ang market, nagbabayad ang iyong "Yes" shares ng $1 bawat isa. Kung mali, nagbabayad ang mga ito ng $0. Maaari ka ring magbenta ng iyong shares anumang oras bago ang resolution kung gusto mong i-lock in ang kita o bawasan ang pagkalugi.

Ang kasalukuyang frontrunner para sa "Mga kaso ng tigdas sa US sa 2026?" ay "↑3.5k" sa 100%, ibig sabihin itinatakda ng market ang 100% na tsansa sa outcome na iyon. Ang sumunod na pinaka-malapit na outcome ay "↑500" sa 100%. Nag-a-update ang mga odds na ito sa real-time habang bumibili at nagbebenta ang mga trader ng shares, kaya sinasalamin nila ang pinakabagong kolektibong view kung ano ang pinaka-malamang na mangyari. Bumalik nang madalas o i-bookmark ang pahinang ito para sundan kung paano nagbabago ang odds habang lumilitaw ang bagong impormasyon.

Ang mga resolution rules para sa "Mga kaso ng tigdas sa US sa 2026?" ay tiyak na nagde-define kung ano ang kailangang mangyari para sa bawat outcome na maideklara bilang panalo — kasama ang mga opisyal na data source na ginagamit para matukoy ang resulta. Maaari mong i-review ang kumpletong resolution criteria sa "Rules" section sa pahinang ito sa itaas ng mga komento. Inirerekomenda namin na basahin nang mabuti ang mga patakaran bago mag-trade, dahil tinutukoy nila ang mga tiyak na kondisyon, edge cases, at mga source na namamahala kung paano nise-settle ang market na ito.